17h
MedPage Today on MSNSTRIDE: Semaglutide Shows it Has Legs in Peripheral Artery DiseaseCHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...
German investment in China’s auto industry has been one of the few bright spots as foreign investment has slowed to a crawl.
In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard ...
Individuals testing positive for human papillomavirus (HPV) had a 40% greater risk for overall cardiovascular disease (CVD) ...
The drugmaker plans to build a research-and-development center in Beijing and strike deals with local biotechnology companies ...
China reassured executives from American and European firms, including Apple, Qualcomm, Mastercard, Pfizer and AstraZeneca, ...
Explore more
Danish Prime Minister Mette Frederiksen pledged Tuesday that her government would resist what she called the unacceptable ...
For this article, we used a Finviz screener to filter all the available ADR stocks. Then we compare the list with our Q4 2024 ...
Berenberg Bank reaffirmed their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report sent to ...
Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned ...
Xponance Inc. raised its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 6.9% during the fourth quarter, ...
Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results